On this page:

Supporting media manufacturing for bioprocessing workflows

Qualifying a cell culture media manufacturer requires confidence in supply continuity, documented evidence of product safety practices, and a manufacturing quality system capable of supporting regulatory review. For bioprocess teams developing or scaling biologics, vaccines, or cell therapy products, gaps in these areas introduce risk at critical stages of the program.

 

The Miami, Florida, facility is a commercial cell culture media manufacturing site designed to support qualification requirements.


Facility highlights

Capabilities that optimize media production

The facility's powder manufacturing operations span a two-building, 12-acre campus and are used to produce cell culture media and supplements at commercial scale. Animal origin-free (AOF) standards and ISO 9001-aligned quality systems are applied throughout production, from raw material intake through finished product release.

 

Powder manufacturing

The Miami location’s powder manufacturing operations produce peptone supplements and dry powder media (DPM) for commercial bioprocessing applications. Peptone supplements serve as hydrolysate-based nutrient sources commonly used to support cell growth, productivity, and media optimization in upstream bioprocessing workflows. Dry powder media formats are widely used across vaccine, biologic, and cell culture applications where reconstitution flexibility and storage efficiency are relevant to manufacturing operations. Production at the facility is conducted under harmonized global manufacturing processes, aligning its operational standards with those used at other Thermo Fisher Scientific cell culture media manufacturing locations.

 

Animal origin-free facility

The Miami facility operates as an AOF facility, meaning the media, reagents, and supplements manufactured here are produced without animal-derived raw materials. AOF status is directly relevant to risk management and regulatory documentation requirements. Regulatory agencies increasingly require traceability and risk assessment for raw materials used in biologics manufacturing. Animal-derived components introduce adventitious agent risk that many programs seek to avoid. Working with an AOF-certified manufacturing source can support raw material qualification documentation, help teams address auditor inquiries regarding raw material sourcing, and reduce the risk-mitigation burden associated with animal-origin materials in the manufacturing supply chain.

 

Quality and ISO 9001 compliance

ISO 9001 certification reflects the site's commitment to operating under a documented quality management system in its commercial manufacturing operations. ISO 9001 offers a recognized framework for evaluating whether a supplier's quality systems are documented, auditable, and consistently applied. The certification supports the supplier's qualification process by demonstrating that quality controls governing production, raw material management, and process documentation at the site meet an independently verified standard. Miami's ISO 9001 certification also aligns with the broader quality framework used throughout the global manufacturing network, giving customers confidence in consistent quality standards across multiple supply locations.


View the Miami, FL facility

Explore bioprocess facility tours

The Miami facility is one site within Thermo Fisher Scientific's connected network of global bioprocessing manufacturing and development locations. Explore the full range of available facility tours.

For Research Use or Further Manufacturing. Not for diagnostic use or direct administration into humans or animals.